Asimov · 1 month ago
Scientist, Viral Vector Process Development
Boston, MA
Full-time
Onsite
Entry, Mid Level
$120K/yr - $130K/yr
6+ years expAsimov is a synthetic biology startup focused on designing living systems for biotechnologies. They are seeking a Scientist I/II in Viral Vector Process Development to conduct process engineering for gene therapies and improve workflows, collaborating with various teams and external partners.
Artificial Intelligence (AI)BiotechnologySoftwareTherapeutics
Responsibilities
Be involved in projects that include media/feed optimization, bioreactor process development, process scale-up and characterization at Ambr15, Ambr250, and benchtop scale, along with analytical assay development focused primarily on LV/AAV, with overlap into biologics
Work together with the Commercial team to technology transfer developed upstream processes to external partners
Create and optimize throughput and robustness of workflows for cell line characterization (transient/stable), small scale screening assays, and product quality assessment
Collaborate with our internal process modeling team to test hypotheses for developing robust predictive models using DOE approaches, machine learning algorithms, and multi-omics analysis
Author, review, and approve process development reports and technology transfer protocols
Support clarifications, downstream processing/purification, and product quality assessment with analytical tools
Represent the process development team on cross-functional projects, making decisions for process development activities and effectively communicating results, progress and plans
Qualification
Required
You have a Bachelors in Biological Engineering, Chemical Engineering, Cell Biology, Molecular Biology, or a related field with 6-8 years of hands-on industry experience performing viral vector process development in support of gene therapies; alternatively, a MS with 3-4 years or PhD with 0-2 years of this type of experience
You're a creative problem solver and get excited about the opportunity to drive the creation of industry-disruptive technology
HEK293-based viral vector process development is squarely in your wheelhouse
You have experience with Ambr15, Ambr250, and/or benchtop scale viral vector bioreactor processes
Being detail-oriented isn't just a sound bite for you, it's part of your DNA
Keeping track of a bunch of moving parts is easy for you because you're highly organized
It's not your first time following a standardized workflow or pipeline
You are an expert in spreadsheets such as Google Sheets or Excel and ideally Spotfire, Google Apps Script (JavaScript) and/or BigQuery to facilitate data management and analysis
Experienced with using DOE software to develop robust experiments
Preferred
Additional CHO-based experience is not required but preferable
Analytical development and downstream purification experience is also highly preferable
Experience in the technology transfer of manufacturing processes and CMC filing in the pharmaceutical industry is desirable
Familiarity with implementing algorithm-based design approaches is a plus
Company
Asimov
Asimov employs artificial intelligence to develop tools for the design and manufacture of next-generation therapeutics.
11-50 employees
H1B Sponsorship
Asimov has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (5)
2024 (2)
2023 (1)
2022 (2)
Funding
Current Stage
Growth StageTotal Funding
$205MKey Investors
CPP InvestmentsHorizons VenturesAndreessen Horowitz
2023-01-05Series B· $175M
2020-01-01Series A· $25M
2017-12-19Seed· $5M
Leadership Team
Alec Nielsen
Co-founder & CEO
Christopher Voigt
Co-Founder
Recent News
Andreessen Horowitz
2026-01-12
2026-01-12
alleywatch.com
2026-01-12
Company data provided by crunchbase